Xolair took over 20 years to be approved for food allergies despite showing benefits in allergy patients, highlighting delayed access to innovative treatments.
Xolair took over 20 years to be approved for food allergies despite showing benefits in allergy patients, highlighting delayed access to innovative treatments.
A needle-less alternative to EpiPen has FDA approval. Will doctors prescribe it?
The newly approved nasal spray Neffy offers a potential alternative to EpiPens, but concerns remain regarding its efficacy in treating life-threatening allergic reactions.